Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision
Previous revision
Both sides next revision
covid-19_therapeutics_task_force [2023/04/29 07:43]
liam [Members]
covid-19_therapeutics_task_force [2023/04/30 06:47] (current)
liam [History]
Line 3: Line 3:
 The **COVID-19 Therapeutics Task Force** was a Canadian public-private advisory body convened by [[Innovation, Science and Economic Development Canada]] (ISED).((Innovation, Science and Economic Development Canada. (2022, March 10). //COVID-19 Therapeutics Task Force.// Government of Canada. http://archive.today/2023.04.27-230206/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force)) The **COVID-19 Therapeutics Task Force** was a Canadian public-private advisory body convened by [[Innovation, Science and Economic Development Canada]] (ISED).((Innovation, Science and Economic Development Canada. (2022, March 10). //COVID-19 Therapeutics Task Force.// Government of Canada. http://archive.today/2023.04.27-230206/https://ised-isde.canada.ca/site/canadian-life-science-industries/en/covid-19-therapeutics-task-force))
  
 +===== History =====
 +
 +[[Navdeep Bains]], Minister of Innovation, Science and Industry, announced the membership of the COVID-19 Therapeutics Task Force on August 5, 2020.((Jagric, A., Roy, C., Innovation, Science and Economic Development Canada, & Public Services and Procurement Canada. (2020, August 5). //Government of Canada announces major steps in treating and preventing COVID-19 through vaccines and therapies.// Government of Canada. http://archive.today/2022.12.16-235932/https://www.canada.ca/en/innovation-science-economic-development/news/2020/08/government-of-canada-announces-major-steps-in-treating-and-preventing-covid-19-through-vaccines-and-therapies.html)) Bains also announced the membership of the [[COVID-19 Vaccine Task Force]].
 ===== Members ===== ===== Members =====
  
Line 14: Line 17:
 | [[Ali Tehrani]]  | Member  | [[pharmaceutical_companies:Zymeworks]], [[Student Biotechnology Network]] (SBN), [[Consortium de recherche biopharmaceutique]] (CQDM), [[Life Sciences British Columbia]], [[Mitacs]], [[BIOTECanada]], [[Premier's Technology Council]], [[pharmaceutical_companies:Creatus Biosciences]]  | | [[Ali Tehrani]]  | Member  | [[pharmaceutical_companies:Zymeworks]], [[Student Biotechnology Network]] (SBN), [[Consortium de recherche biopharmaceutique]] (CQDM), [[Life Sciences British Columbia]], [[Mitacs]], [[BIOTECanada]], [[Premier's Technology Council]], [[pharmaceutical_companies:Creatus Biosciences]]  |
 | [[Youla Tsantrizos]]  | Member  | [[McGill University]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Centre de recherche en biologie structurale]] (CRBS), [[Canadian Society for Chemistry]], [[Natural Sciences and Engineering Research Council of Canada]] (NSERC), [[Canadian Institutes of Health Research]] (CIHR), [[Ontario Institute for Cancer Research]] (OICR)  | | [[Youla Tsantrizos]]  | Member  | [[McGill University]], [[pharmaceutical_companies:Boehringer Ingelheim]], [[Centre de recherche en biologie structurale]] (CRBS), [[Canadian Society for Chemistry]], [[Natural Sciences and Engineering Research Council of Canada]] (NSERC), [[Canadian Institutes of Health Research]] (CIHR), [[Ontario Institute for Cancer Research]] (OICR)  |
 +^  Advisors  ^^^
 +| [[Lisa Barrett]]  | Advisor  | [[Dalhousie University]], [[Senescence Aging Infection & Immunity Lab]] (SAIL), [[National Institute of Allergy and Infectious Diseases]] (NIAID)  |
 +| [[Marceline Côté]]  | Advisor  | [[University of Ottawa]]  |
 +| [[Eleanor Fish]]  | Advisor  | [[University of Toronto]], [[University Health Network]] (UHN)  |
 +| [[Matthias Götte]]  | Advisor  | [[Li Ka Shing Institute of Virology]], [[McGill University]]  |
 +| [[François Jean]]  | Advisor  | [[Facility for Infectious Disease and Epidemic Research]] (FINDER)  |
 +| [[Samira Mubareka]]  | Advisor  | [[Sunnybrook Health Sciences Centre]], [[University of Toronto]], [[Centre for Research Expertise in Occupational Disease]] (CREOD), [[Canadian COVID-19 Genomics Network]] (CanCOGen), [[Genome Canada]], [[Ontario's COVID-19 Genomics Rapid Response Coalition]] (ONCoV), [[Ontario Academic Health Sciences SARS-CoV-2 Sequencing Network]] (ONS2), [[Sunnybrook Translational Research Group for Emerging Respiratory Viruses]] (SERV)  |
 +| [[Pamela Ohashi]]  | Advisor  | [[Princess Margaret Cancer Centre]], [[University of Toronto]], [[American Association for Cancer Research]] (AACR), [[Society for Immunotherapy of Cancer]] (SITC), [[Royal Society of Canada]] (RSC)  |
 +| [[James Russell]]  | Advisor  | [[University of British Columbia]] (UBC), [[Centre for Heart Lung Innovation]] (HLI), [[Sirius Genomics]], [[pharmaceutical_companies:Cyon Therapeutics]], [[St. Paul's Hospital]]  |
 +| [[Makeda Semret]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[Joint Programming Initiative on Antimicrobial Resistance]] (JPIAMR), [[AAU-McGill Partnership for Infectious Diseases]] (AMP-ID)  |
 +| [[Don Sheppard]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[McGill Interdisciplinary Initiative in Infection and Immunity]] (MI4)  |
 +| [[Don Vinh]]  | Advisor  | [[McGill University Health Centre]] (MUHC), [[Canadian Glycomics Network]] (GlycoNet), [[Association of Medical Microbiology and Infectious Disease Canada]] (AMMI), [[Clinical Immunology Society]] (CIS), [[Comité consultatif québécois pour les maladies rares]], [[MUHC COVID-19 Biobank]], [[COVID-19 and Cancer Consortium]] (CCC19), [[COVID Human Genetic Effort]] (CHGE)  |
 +
 +===== External links =====
 +
 +  * [[http://covidtruthinitiative.ca/Organizations/COVID-19-Therapeutics-Task-Force|COVID Truth Initiative]]
Back to top